These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12704661)

  • 21. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
    DeMeester SR; Wickramasinghe KS; Lord RV; Friedman A; Balaji NS; Chandrasoma PT; Hagen JA; Peters JH; DeMeester TR
    Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation.
    Dumoulin FL; Terjung B; Neubrand M; Scheurlen C; Fischer HP; Sauerbruch T
    Endoscopy; 1997 Oct; 29(8):751-3. PubMed ID: 9427496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.
    Byrne JP; Armstrong GR; Attwood SE
    Am J Gastroenterol; 1998 Oct; 93(10):1810-5. PubMed ID: 9772036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
    Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
    Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus.
    Nishigaki H; Wada K; Tatsuguchi A; Sueoka N; Futagami S; Gudis K; Miyake K; Tsukui T; Sakamoto C
    Digestion; 2004; 70(2):95-102. PubMed ID: 15375338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low glutathione and glutathione S-transferase levels in Barrett's esophagus as compared to normal esophageal epithelium.
    van Lieshout EM; Tiemessen DM; Witteman BJ; Jansen JB; Peters WH
    Jpn J Cancer Res; 1999 Jan; 90(1):81-5. PubMed ID: 10076569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Argon plasma coagulation in Barrett's esophagus].
    Nomura T; Yamashita K; Miyashita M; Tajiri T
    Nihon Rinsho; 2005 Aug; 63(8):1458-62. PubMed ID: 16101240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of Barrett's esophagus.
    Chandrasoma P
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of claudins and prognostic factors in some gastrointestinal diseases].
    Gyorffy H
    Magy Onkol; 2009 Dec; 53(4):377-83. PubMed ID: 20071310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutathione and glutathione S-transferases in Barrett's epithelium.
    Peters WH; Roelofs HM; Hectors MP; Nagengast FM; Jansen JB
    Br J Cancer; 1993 Jun; 67(6):1413-7. PubMed ID: 8512826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Squamous reepithelialization after circumferential endoscopic mucosal resection of superficial carcinoma arising in Barrett's esophagus.
    Satodate H; Inoue H; Fukami N; Shiokawa A; Kudo SE
    Endoscopy; 2004 Oct; 36(10):909-12. PubMed ID: 15452789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress has a role in malignant transformation in Barrett's oesophagus.
    Sihvo EI; Salminen JT; Rantanen TK; Rämö OJ; Ahotupa M; Färkkilä M; Auvinen MI; Salo JA
    Int J Cancer; 2002 Dec; 102(6):551-5. PubMed ID: 12447994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ornithine decarboxylase activity in Barrett's esophagus: a potential marker for dysplasia.
    Garewal HS; Sampliner R; Gerner E; Steinbronn K; Alberts D; Kendall D
    Gastroenterology; 1988 Mar; 94(3):819-21. PubMed ID: 3338650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
    Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
    Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus.
    Going JJ; Fletcher-Monaghan AJ; Neilson L; Wisman BA; van der Zee A; Stuart RC; Keith WN
    Neoplasia; 2004; 6(1):85-92. PubMed ID: 15068673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
    Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
    Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
    Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
    Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.